IL-15 has been reported to be involved in a number of autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, in which IL-15 promotes the effector function of cytotoxic CD8+ T cells to destroy the target tissues [62]. Here, CD8A is linked to inflammatory bowel disease.